权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Wearable Compression Sensor for Medical Applications - ComSense

适用于医疗应用的可穿戴压力传感器 - ComSense

基本信息

批准号：
44379
负责人：
金额：
$ 17.75万
依托单位：
OXFORD HEALTHTECH LTD.
依托单位国家：
英国
项目类别：
Study
财政年份：
2020
资助国家：
英国
起止时间：
2020 至无数据
项目状态：
已结题

来源：
https://gtr.ukri.org/projects?ref=44379
关键词：
Wearable Compression Sensor Medical Applications

项目摘要

Compression therapy (CT) via an elasticated compression garment (CG), is widely used for the treatment and management of venous deficiencies which cause venous leg ulcers (VLU) and in assisting the movement and removal of trapped fluid in the body's lymphatic system which causes lymphoedema.VLU and lymphoedema are long-term chronic medical conditions. It can take months and sometimes years to heal. Over 400,000 people in the UK suffer from lymphoedema and more than 300,000 people are affected by venous leg ulcers. VLU and lymphoedema conditions pose considerable human and social complications, causing physical discomfort, economic burden (loss of/time off work) and loss of self-confidence. Associated psychological effects including distress, depression and anxiety are immeasurable. The cost to the NHS for treating VLU and lymphoedema exceeds £2 billion and £0.5 billion pa respectively.Compression therapy is a critical treatment & management procedure for VLU and lymphedema. It involves the application of a pressure on the affected region of the body (usually the arm and/or leg). It is important to know the amount of pressure being applied at the skin-garment interface - this has consequence on healing. However, currently there is no technology available which can accurately measure the interface pressure.Oxford Healthtech Ltd., is developing a novel technology which will allow the accurate measurement of compression pressure and record data. This is expected to improve healing times and also help clinicians and carers to make well informed decisions.

通过弹性加压衣（CG）的加压疗法（CT）被广泛用于治疗和管理引起下肢静脉溃疡（VLU）的静脉缺陷，以及辅助移动和清除引起淋巴水肿的身体淋巴系统中的滞留液体。VLU和淋巴水肿是长期慢性医学病症。可能需要数月甚至数年才能痊愈。在英国，超过40万人患有淋巴水肿，超过30万人受到腿部静脉溃疡的影响。VLU和淋巴水肿状况造成相当大的人类和社会并发症，导致身体不适，经济负担（失去工作/休假）和自信心的丧失。相关的心理影响，包括痛苦，抑郁和焦虑是不可估量的。NHS治疗VLU和淋巴水肿的费用分别超过20亿英镑和5亿英镑。压迫疗法是VLU和淋巴水肿的关键治疗和管理程序。它涉及对身体的受影响区域（通常是手臂和/或腿部）施加压力。重要的是要知道施加在皮肤-服装界面的压力大小-这对愈合有影响。然而，目前还没有可以精确测量界面压力的技术。正在开发一种新技术，可以准确测量压缩压力并记录数据。预计这将缩短愈合时间，并帮助临床医生和护理人员做出明智的决定。